For the second time in under 3 weeks, the FDA has approved treatment for the inherited genetic disorder characterized by ...

One analyst described Cogent’s data as a “home run scenario” for bezuclastinib, which the company is positioning as a a ...

The treatment marks the only targeted oral treatment in patients with non–small cell lung cancer with epidermal growth factor ...

Health officials have urgently recalled over 11,000 eye drops due to fears over contamination that could cause blindness.